Raphael Pharmaceutical (RAPH) Other Accumulated Expenses (2025)
Raphael Pharmaceutical (RAPH) reported Other Accumulated Expenses of $297700.0 for Q4 2025.
Raphael Pharmaceutical (RAPH) Other Accumulated Expenses (2025) Analysis & Trends
Raphael Pharmaceutical (RAPH) has 1 years of Other Accumulated Expenses data on file, last reported at $297700.0 in Q4 2025.
- For the quarter ending Q4 2025, Other Accumulated Expenses changed N/A year-over-year to $297700.0; the trailing twelve-month figure through Dec 2025 stood at $297700.0 (changed N/A YoY), and the FY2025 full-year result was $297700.0, changed N/A from the prior year.
- Other Accumulated Expenses steadied at $297700.0 in Q4 2025.
- In the past five years, Other Accumulated Expenses ranged from a high of $297700.0 in Q4 2025 to a low of $297700.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Raphael Pharmaceutical | 27.37 Mn | 27.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 297,700.00 |